Immune Checkpoint Inhibitors in Organ Transplant Patients von Kittai, Adam S, Oldham, Hayden, Cetnar, Jeremy, Taylor, Matthew

Volltext

uMRD: “the” endpoint or “an” endpoint for CLL? von Kittai, Adam S., Woyach, Jennifer A.

Volltext

Richter’s Transformation von Sigmund, Audrey M., Kittai, Adam S.

Volltext

Treatment of Richter’s Transformation with Novel Therapies von Bajwa, Amneet, Habib, Alma, Kittai, Adam S.

Volltext

The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib von Kittai, Adam S., Miller, Cecelia, Goldstein, Daniel, Huang, Ying, Abruzzo, Lynne V., Beckwith, Kyle, Bhat, Seema A., Bond, David A., Grever, Michael R., Heerema, Nyla A., Rogers, Kerry A., Ruppert, Amy S., Byrd, John C., Woyach, Jennifer A.

Volltext

Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis von Kittai, Adam S., Huang, Ying, Gordon, Max, Denlinger, Nathan, Mian, Agrima, Fitzgerald, Lindsey, Bishop, Jennifer, Nagle, Sarah, Stephens, Deborah M., Jaglowski, Samantha, Hill, Brian, Danilov, Alexey V.

Volltext

Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation von Gambril, John Alan, Ghazi, Sanam M., Sansoterra, Stephen, Ferdousi, Mussammat, Kola-Kehinde, Onaopepo, Ruz, Patrick, Kittai, Adam S., Rogers, Kerry, Grever, Michael, Bhat, Seema, Wiczer, Tracy, Byrd, John C., Woyach, Jennifer, Addison, Daniel

Volltext

Cellular Therapy Advances in Chronic Lymphocytic Leukemia and Richter's Syndrome von Bajwa, Amneet, Voorhees, Timothy J., Kittai, Adam S.

Volltext

Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia von Avenarius, Matthew R., Huang, Ying, Kittai, Adam S., Bhat, Seema A., Rogers, Kerry A., Grever, Michael R., Woyach, Jennifer A., Miller, Cecelia R.

Volltext

Novel Approaches to Richter Syndrome von Marchal, Isabella S, Kittai, Adam S

Volltext

Evaluation of bleeding events in patients receiving acalabrutinib therapy von Kumar, Pooja S., Wiczer, Tracy, Rosen, Lindsay, Pollauf, Arthur J., Zheng, Amy, Palettas, Marilly, Azali, Leylah, Bhat, Seema A., Byrd, John C., Grever, Michael R., Rogers, Kerry A., Woyach, Jennifer A., Kittai, Adam S.

Volltext

Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy von Kumar, Pooja S., Wiczer, Tracy, Rosen, Lindsay, Pollauf, Arthur J., Zheng, Amy, Palettas, Marilly, Azali, Leylah, Bhat, Seema A., Byrd, John C., Grever, Michael R., Rogers, Kerry A., Woyach, Jennifer A., Kittai, Adam S.

Volltext

TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma von Gordon, Max J, Bond, David A, Kittai, Adam S, Amirmokhtari, Neda, Steinbrunner, Abigail, Huffman, Allison, Orellana-Noia, Victor, Shouse, Geoffrey, Cohen, Jonathon B, Phillips, Tycel, Danilov, Alexey V

Volltext

Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib von Sigmund, Audrey M., Huang, Ying, Ruppert, Amy S., Maddocks, Kami, Rogers, Kerry A., Jaglowski, Samantha, Bhat, Seema A., Kittai, Adam S., Grever, Michael R., Byrd, John C., Woyach, Jennifer A.

Volltext

Coronado CLL: A Phase Ib/II Trial of Combination Rp-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refract ory Chronic Lymphocytic Leukemia von Hu, Boyu, Kittai, Adam S, Boucher, Kenneth, Pomicter, Tony, Stephens, Deborah M.

Volltext

A matching‐adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia von Kittai, Adam S., Skarbnik, Alan, Miranda, Miguel, Yong, Alan S. M., Roos, Jack, Hettle, Robert, Palazuelos‐Munoz, Sarah, Shetty, Vikram, Ghia, Paolo

Volltext

Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies von Kittai, Adam S, Best, Scott, Thurlow, Bria, Lam, Vi, Hashiguchi, Taylor, Goodyear, Shaun, Persky, Daniel O, Okada, Craig, Park, Byung, Spurgeon, Stephen E, Danilov, Alexey V

Volltext

A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers von Kawakami, Masanori, Mustachio, Lisa Maria, Chen, Yulong, Chen, Zibo, Liu, Xiuxia, Wei, Cheng-Hsin, Roszik, Jason, Kittai, Adam S, Danilov, Alexey V, Zhang, Xiaoshan, Fang, Bingliang, Wang, Jing, Heymach, John V, Tyutyunyk-Massey, Liliya, Freemantle, Sarah J, Kurie, Jonathan M, Liu, Xi, Dmitrovsky, Ethan

Volltext

Evaluating depth of disparities in relation to relative survival rates: Analysis of SEER data von Habib, Alma, Huang, Ying, Paskett, Electra D., Devarakonda, Srinivas S., Fisher, James L., Kittai, Adam

Volltext

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study von Epperla, Narendranath, Feng, Lei, Shah, Nirav N, Fitzgerald, Lindsey, Shah, Harsh, Stephens, Deborah M, Lee, Catherine J, Ollila, Thomas, Shouse, Geoffrey, Danilov, Alexey V, David, Kevin A, Torka, Pallawi, Hashmi, Hamza, Hess, Brian, Barta, Stefan K, Romancik, Jason T, Cohen, Jonathon B, Annunzio, Kaitlin, Kittai, Adam S, Reneau, John, Zurko, Joanna, Nizamuddin, Imran A, Winter, Jane N, Gordon, Leo I, Ma, Shuo, Patel, Romil, Nastoupil, Loretta, Ahmed, Sairah, Karmali, Reem

Volltext